---
layout: page
title: Publications
description: Ryan Sun's publications
---


### <a name="articles"></a>Journal Articles

**Sun R**\*, Bouchard MB\*, Hillman EMC.
SPLASSH: open source software for camera-based high-speed, multispectral in-vivo optical image acquisition. 
*Biomedical Optics Express 2010*; 1(2): 375-397.

Wang Z, Claus-Henn B, Wang C, Wei Y, Su L, **Sun R**, Chen H, Wagner PJ, Lu Q, Lin x, Wright R, Bellinger D, Kile M, Mazumdar M, Tellez-Rojo MM, Schaas L, Christiani DC. 
Genome-wide gene by Pb exposure interaction analysis identifies UNC5D as a candidate gene for neurodevelopment.
*Environmental Health* 2-17; 16(1): 81.

**Sun R**, Carroll RJ, Christiani DC, Lin X. Testing for gene-environment interaction under exposure misspecification.
*Biometrics* 2018; 74(2): 653-662.

Orkaby A, Rich MW, **Sun R**, Lux E, Wei LJ, Kim DH. Pravastin for primary prevention in older adults: restricted mean survival time analysis. 
*Journal of the American Geriatric Society* 2018; 66(10): 1987-1991.

**Sun R**, Wang Z, Claus-Henn B, Su L, Lu Q, Lin X, Wright R, Bellinger D, Kile M, Mazumdar M, Tellez-Rojo MM, Schnaas L, Christiani DC. 
Identification of novel loci associated with infant cognitive ability. 
*Molecular Psychiatry* Molecular Psychiatry 2018; 1-10.

**Sun R**, Hui S, Bader G, Lin X, Kraft P.
Powerful gene set analysis in GWAS with the Generalized Berk-Jones statistic.
*PLOS Genetics* 2019; 15(3): e1007530.

Gaynor S\*; **Sun R**\*, Lin X, Quackenbush J. Identification of differentially expressed gene sets using the Generalized Berk-Jones statistic.
*Bioinformatics* 2019; 35(22): 4568-4576.

**Sun R**, Lin X. Set-based tests for genetic association using the Generalized Berk-Jones statistic.
*Journal of the American Statistical Association* 2020; 115(53): 1079-1091.

Park, H-R., Panganibana, R.A., **Sun, R.**, Shumyatcher, M., Himes, B.E., Christiani, D.C., Lu, Q. 
MicroRNA-124 protects neural cells against arsenic-induced endoplasmic reticulum stress and cytotoxicity in vitro and is associated with neurodevelopmental outcomes in children. *Scientific Reports* 2020; 10(1): 1-11.

Li, X., Li, Z., Zhou, H., Gaynor, S., Liu, Y., Chen, H., **Sun, R.**, ..., Lin, X.
Dynamic incorporation of multiple in-silico functional annotations empowers rare variant association analysis of large whole genome sequencing studies at scale. *Nature Genetics* 2020; 52(9): 969-983.

Colina, A., Hwang H., Wang, H., Katz, M., **Sun, R.**, Lee, J., Tzeng, C., Wolff, R., Raghav, K., Overman, M. 
Natural history and prognostic factors for localized small bowel adenocarcinoma. *ESMO Open* 2020; 5(6): e000960.

Deng, Q., Han, G., Puebla-Osorio, N., Ma, M.C.J., Strati, P., Chasen, B., Dai, E., Dang, M., Jain, N., Yang, H., Wang, Y., Zhang, S., Wang, R., Chen, R., Showell, H., Ghosh, S., Patchva, S., Zhang, Q., **Sun, R.**, ..., Green, M.R.
Characteristics of anti-CD19 CAR T-cell infusion products associated with efficacy and toxicity in patients with large B-cell lymphomas. *Nature Medicine* 2020; 26(12): 18878-1887

Zhu, L., Cai, D., Li, Y., Tong, X., **Sun, R.**, Srivastava, D., Hudson, M. 
Maximum likelihood estimation for the proportional odds model with mixed interval-censored failure time data. *Journal of Applied Statistics* 2021; 48(8):1496-1512.

**Sun, R.**, Xu, M., Li, X., Gaynor, S., Zhou, H., Bosse, Y., Lam, S., Tsao, M., Tardon, A., Chen, C., Doherty, J., Goodman, G., Egil Bojesen, S., Teresa, M.T., Johansson, M., Field, J.K., Bickeboller, H., Wichmann, H., Risch, A., Rennert, G., Arnold, S., Wu, X., Melander, O., Brunnstr Ìˆom, H., Marchand, L.L., Zong, X., Liu, G., Andrew, A., Duell, E., Kiemeney, L.A., Shen, H., Haugen, A., Johansson, M., Grankvist, K., Caporaso, N., Woll, P., Teare, M.D., Scelo, G., Hong, Y., Yuan, J., Lazarus, P., Schabath, M.B., Aldrich, M.C., Albanes, D., Brennan, P., Barbie, D., Mak, R., Hung, R.J., Amos, C.I., Christiani, D.C., Lin, X. 
Identification of inflammation and immune-related risk variants associated with squamous cell lung cancer. *Genetic Epidemiology* 2021; 45(1): 99-114.

Kim, D., Li, X., Bian, S., Wei, L.J., **Sun, R**. 
Effect of dementia drugs on nursing home placement: what is the meaningful metric? *JAMA Network Open* 2021; 4(1): e2034745.

Strati, S., Ahmed, S., Furqan, F., ..., **Sun, R.**, Claussen, C., Hawkins, M., Johnson, N., Singh, P., Mistry, H., Johncy, S., Adkins, S., Kebriaei, P., Shpall, E., Green, M., Flowers, C., Westin, J., Neelapu, S. 
Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor t-cell therapy in large b-cell lymphoma. *Blood* 2021; 137(23): 3272-3276.

Alhalabi, O., Soomro, Z., **Sun, R.**, Hasanov, E., Albittar, A., Tripathy, D., Valero, V., Ibrahim, N. 
Outcomes of changing systemic therapy in patients with relapsed breast cancer and 1 to 3 brain metastases. *NPJ Breast Cancer* 2021; 7(1): 1-5.

Yam, C., Rauch, G., Rahman, T., Karuturi, M., Ravenberg, E., White, J., Clayborn, A., McCarthy, P., Abouharb, S., Lim, B., Litton, J., Ramirez, D., Saleem, S., Stec, J., Symmans, W., Huo, L., Damodaran, S., **Sun, R.**, Moulder, S. 
A phase II study of mirvetuximab soravtansine in triple- negative breast cancer. *Investigational New Drugs* 2021; 39(2): 509-515.

Han, G., Yang, G., Hao, D., Lu, Y., Thein, K., Chen, J., **Sun, R.**, ..., Wang, L. 
9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy. *Nature Communications* 2021; 12(1): 1-19.

Xu, M., Tapia, C., Hajjar, J., ..., **Sun, R.**, Karp, D., Koay, E., Yang, Y., Wistuba, I., Hwu, P., Meric-Bernstam, F., Naing, A. 
Implementation of a novel web-based lesion selection tool to improve acquisition of biopsies. *Journal of Immunotherapy and Precision Oncology* 2021: 4(2): 45-52.

Yam, Y., Yen, E., Chang, T., ..., **Sun, R.**, Moulder, S., Mittendorf E. 
Immune phenotype and response to neoadjuvant therapy in triple-negative breast cancer. *Clinical Cancer Research* 2021; 27(19): 5356-5375.

**Sun, R.**\*, McCaw, Z.\*, Tian, L., Uno, H., Hong, F., Kim, D., Wei, L.J. 
Moving beyond conventional stratified analysis to assess the treatment effect in a comparative oncology study. *Journal for Immunotherapy of Cancer* 2021; 9(11): e003323.

Kaseb, A., Hasanov, E., Cao, H., ..., **Sun, R.**, Vittorio, C., Beretta, L., Yao, J., Wolff, R., Allison, J., Sharma, P. 
Perioperative nivolumab monotherapy plus ipilimumab in resectable hepatocellular carcinoma. *The Lancet Gastroenterology & Hepatology* 2022+ (in press).

Li, Y., Xiao, X., Li, J., ..., **Sun, R.**, ..., Willey, J., Gaba, C., Amos, C. 
Genome-wide interaction analysis identified low-frequency variants with sex disparity in lung cancer risk. *Human Molecular Genetics* 2022+ (in press).

Grover, P., Veilleux O., Tian, L., **Sun, R.**, Previtera, M., Curran, E., Muffly, L. 
Chimeric antigen receptor-T cell therapy in adults with B-cell acute lymphoblastic leukemia: a systematic review. *Blood Advances* 2022+ (in press).

McCaw, Z., Gaynor, S., **Sun, R.**, Lin X. 
Cross-tissue eQTL mapping in the presence of missing data via surrogate outcome analysis. *Biometrics* 2022+ (in press).

Li, X., Yung G., Zhou H., **Sun, R.**, Li, Z., Liu X., Ionita-Laza, I., Lin X. 
A multi-dimensional integrative scoring framework for predicting functional variants in the human genome. *American Journal of Human Genetics* 2022+ (in press).

**Sun, R.**, Liang, Z., Li, Y., Yutaka, Y., Robison, L. Inference for set-based effects in genetic association studies with interval-censored outcomes. *Biometrics* 2022+ (in press).

#### Published Correspondence

**Sun R**, Horiguchi M, Wei LJ.
Interpreting the benefit of frifluirdine/tipiracil in metastatic colorectal cancer with respect to progression-free survival and overall survival.
*Journal of Clinical Oncology* 2018; 36(13): 1378.

**Sun R**, Rich MW, Wei LJ.  Pembrolizumab plus chemotherapy in lung cancer.
*New England Journal of Medicine* 2018; 379(11): e18.

**Sun R**, Nie L, Huang B, Kim DH, Wei LJ. Quantifying immunoscore performance.
*The Lancet* 2018; 392(10158): 1624.

**Sun R**, Wei LJ. Regional Hyperthermia With Neoadjuvant Chemotherapy for Treatment of Soft Tissue Sarcoma.
*JAMA Oncology* 2019; 5(1): 112-113.

**Sun R**, Zhu H, Wei LJ. Assessing the prognostic value of automated bone scan index in prostate cancer.
*JAMA Oncology* 2019; 5(2): 270.

**Sun R**, Orkaby AO, Kim DH, Zhu H, Wei LJ. Interpreting non-inferiority of biodegradable- polymer stents to durable-polymer stents.
*The Lancet* 2019; 393(10184): 1932-1933.

**Sun R**, Lee H, Wei LJ. Interpreting the long-term prognostic value of total mesorectal excision plane quality in rectal adenocarcinoma.
*JAMA Surgery* 2019; 154(1): 96.

**Sun, R.**, Kim, D.H., and Wei, L.J. Analysis of overall survival benefit of abemaciclib plus fulvestrant in hormone receptor-positive, ERBB-2 negative breast cancer. 
*JAMA Oncology* 2020; 6(7): 1121-1122.

**Sun, R.**, Messick, C., and Wei, L.J. Quantifying benefit from two-stage turnbull-cutait pull-through coloanal anastomosis for low rectal cancer. 
*JAMA Surgery* 2021; 156(2): 202-203.

**Sun, R.**, Tian, L., and Wei, L.J. Evaluating long-term efficacy of neoadjuvant chemoradiotherapy plus surgery for the treatment of locally advanced esophageal squamous cell carcinoma. *JAMA Surgery* 2022+ (in press).

\*Indicates equal contribution as first authors.
